Analysis of Risk Factors for Deep Vein Thrombosis Complications after Percutaneous Coronary Intervention in Elderly Patients: A Retrospective Case-Control Survey
DOI:
https://doi.org/10.59958/hsf.7515Keywords:
risk factors, deep vein thrombosis, complications, percutaneous coronary intervention, elderly patientsAbstract
Purpose: The objective of this study is to comprehensively analyze the risk factors associated with deep vein thrombosis (DVT) complications after percutaneous coronary intervention (PCI) in elderly patients. Methods: A retrospective case-control study was conducted by analyzing the data of 101 elderly patients who underwent PCI. On the basis of the occurrence of postoperative DVT, the patients were divided into non-DVT (n = 57) and DVT (n = 44) groups. Baseline characteristics, procedural details, laboratory indicators, medication use, postprocedural complications, length of hospital stay, and rehospitalization were assessed. Results: Procedural characteristics showed lengthened procedural time (45.62 ± 7.81 vs. 42.17 ± 8.43 min, t = 2.105, p = 0.038) and increased contrast volume (161.05 ± 27.56 vs. 150.14 ± 25.67 mL, t = 2.051, p = 0.043) in the DVT group. Significant differences were observed in hemoglobin (13.92 ± 1.58 g/dL vs. 13.18 ± 1.76 g/dL, t = 2.221, p = 0.029) and serum albumin levels (4.33 ± 0.38 g/dL vs. 4.09 ± 0.42 g/dL, t = 3.006, p = 0.034) between the two groups. Moreover, compared with the non-DVT group, the DVT group had longer hospital stays (6.41 ± 2.05 days vs. 5.32 ± 1.76 days, t = 2.872, p = 0.005) and increased rehospitalization rates (27.27% vs. 10.53%, t = 4.755, p = 0.029). Correlation and logistic regression analyses identified several statistically significant associations between the risk factors and complications of DVT in elderly patients with PCI. Conclusion: The present study provides novel insights into the multifaceted nature of DVT after PCI in elderly patients and emphasizes the substantial effects of DVT on clinical outcomes. The findings underscore the need for comprehensive risk assessment, vigilant monitoring, and proactive management of DVT in this patient population to optimize patient outcomes after PCI. Future research should focus on developing targeted interventions and risk stratification tools tailored to the unique needs of elderly patients with PCI to improve clinical treatment.
References
Al Said S, Alabed S, Kaier K, Tan AR, Bode C, Meerpohl JJ, et al. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis. The Cochrane Database of Systematic Reviews. 2019; 12: CD013252.
Beerkens FJ, Singh R, Cao D, Claessen BE, Nicolas J, Sartori S, et al. Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft. Catheterization and Cardiovascular Interventions. 2021; 98: E785–E795.
Bhogal S, Kallur A, Merdler I, Ben-Dor I, Devineni A, Hashim HD, et al. Aspiration Thrombectomy With and Without Cangrelor During Percutaneous Coronary Intervention. The American Journal of Cardiology. 2023; 209: 89–91.
Bai M, Lu A, Pan C, Hu S, Qu W, Zhao J, et al. Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions. Frontiers in Medicine. 2022; 9: 913403.
Bhogal S, Panchal HB, Bagai J, Banerjee S, Brilakis ES, Mukherjee D, et al. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials. Cardiovascular Revascularization Medicine: Including Molecular Interventions. 2019; 20: 758–767.
Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nature Reviews. Cardiology. 2023; 20: 248–262.
Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis. Clinical and Experimental Medicine. 2023; 23: 645–654.
Kaneko T, Nakamura S, Hayakawa K, Tokimura F, Miyazaki T. Preoperative incidence and risk factors of deep vein thrombosis in Japanese patients undergoing total hip arthroplasty. European Journal of Orthopaedic Surgery & Traumatology: Orthopedie Traumatologie. 2023; 33: 2859–2864.
Simon MA, Klaeffling C, Ward J, Rauchfuss S, Miesbach W. Clinical Outcome of Deep Vein Thrombosis Is Related to Thrombophilic Risk Factors. Clinical and Applied Thrombosis/Hemostasis. 2023; 29: 10760296231152898.
Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic Vein Thrombosis: Current Perspectives. Vascular Health and Risk Management. 2019; 15: 449–461.
Shi Y, Wang T, Yuan Y, Su H, Chen L, Huang H, et al. Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors. Clinical and Applied Thrombosis/Hemostasis. 2022; 28: 10760296221131034.
Lo Faro V, Johansson T, Höglund J, Hadizadeh F, Johansson Å. Polygenic risk scores and risk stratification in deep vein thrombosis. Thrombosis Research. 2023; 228: 151–162.
Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, et al. A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. International Journal of Molecular Sciences. 2023; 24: 3169.
Fujioka S, Ohkubo H, Kitamura T, Mishima T, Onishi Y, Tadokoro Y, et al. Risk Factors for Progression of Distal Deep Vein Thrombosis. Circulation Journal. 2020; 84: 1862–1865.
Goldhaber SZ, Magnuson EA, Chinnakondepalli KM, Cohen DJ, Vedantham S. Catheter-directed thrombolysis for deep vein thrombosis: 2021 update. Vascular Medicine. 2021; 26: 662–669.
Iding AFJ, Pallares Robles A, Ten Cate V, Ten Cate H, Wild PS, Ten Cate-Hoek AJ. Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence. Journal of Thrombosis and Haemostasis. 2023; 21: 1238–1247.
van Minnen O, van den Bergh WM, Droogh JM, Koehorst L, Lagrand WK, Raasveld SJ, et al. Incidence and risk factors of deep vein thrombosis after extracorporeal life support. Artificial Organs. 2022; 46: 1893–1900.
Wenger N, Sebastian T, Engelberger RP, Kucher N, Spirk D. Pulmonary embolism and deep vein thrombosis: Similar but different. Thrombosis Research. 2021; 206: 88–98.
Huang Y, Nong JG, Xue Q, Feng QZ, Lu CY. The efficacy of the figure-of-eight suture technique in the treatment of tunnel bleeding of the femoral artery route after percutaneous coronary intervention or angiography. The Journal of International Medical Research. 2020; 48: 300060520947307.
Keskin G, Khalil E, Uysal A. Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic? The Heart Surgery Forum. 2021; 24: E022–E030.
Katsoularis I, Fonseca-Rodríguez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ (Clinical Research Ed.). 2022; 377: e069590.
Wang T, Guo J, Long Y, Yin Y, Hou Z. Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis. Journal of Orthopaedics and Traumatology. 2022; 23: 19.
Lo MY, Chen MS, Jen HM, Chen CC, Shen TY. A rare complication of cerebral venous thrombosis during simple percutaneous coronary intervention: A case report. Medicine. 2021; 100: e24008.
Rgeeb AN, Alsalkh HA, Radhi AK, Amber K. Effect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact. Medical Archives. 2020; 74: 265–269.
Seo J, Lee J, Shin YH, Jang AY, Suh SY. Acute myocardial infarction after initially diagnosed with unprovoked venous thromboembolism: A case report. World Journal of Clinical Cases. 2023; 11: 7497–7501.
Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thrombosis Research. 2020; 187: 103–112.
Camm AJ, Sabbour H, Schnell O, Summaria F, Verma A. Managing thrombotic risk in patients with diabetes. Cardiovascular Diabetology. 2022; 21: 160.
Tallon EM, Gallagher MP, Staggs VS, Ferro D, Murthy DB, Ebekozien O, et al. Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data™. BMJ Open. 2023; 13: e071475.
Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021; 398: 64–77.
Xiong X, Cheng B. Preoperative risk factors for deep vein thrombosis in knee osteoarthritis patients undergoing total knee arthroplasty. Journal of Orthopaedic Science. 2023; 28: 180–187.
Lu Y, Rong L, Ding C. The correlation between iron deficiency anemia and the occurrence and prognosis of cardiovascular diseases in the elderly [J]. Chinese Journal of Gerontology. 2023; 43: 517–519. (In Chinese)
Johnson RR, Faustino EVS. Central venous catheter-associated deep vein thrombosis in critically ill pediatric patients: risk factors, prevention, and treatment. Current Opinion in Pediatrics. 2022; 34: 273–278.
Published
How to Cite
Issue
Section
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
